Cargando…

The introduction of ticagrelor is associated with lower rates of recurrent ischemic stroke after myocardial infarction

BACKGROUND: Previous ischemic stroke is a predictor of recurrent ischemic stroke after an acute myocardial infarction (AMI). Dual antiplatelet therapy, including a P2Y12-inhibitor, is important in secondary prevention after AMI. Ticagrelor, a P2Y12-inhibitor, is more potent than the commonly used cl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Henriksson, Robin, Björklund, Fredrik, Mooe, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502343/ https://www.ncbi.nlm.nih.gov/pubmed/31059535 http://dx.doi.org/10.1371/journal.pone.0216404

Ejemplares similares

Increase in ticagrelor use over time is associated with lower rates of ischemic stroke following myocardial infarction
por: Henriksson, Robin, et al.
Publicado: (2019)

Risk of Ischemic Stroke After Acute Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery
por: Åström, André, et al.
Publicado: (2020)

Ticagrelor versus clopidogrel for recurrent myocardial infarction: An outcomes-based agreement
por: Peasah, Samuel K., et al.
Publicado: (2023)

Effects of Ticagrelor on Myocardial Infarct Size
por: Hahn, Joo-Yong
Publicado: (2017)

The impact of platelet function or C-reactive protein, on cardiovascular events after an acute myocardial infarction
por: Modica, Angelo, et al.
Publicado: (2009)

Will Ticagrelor Help Post-Myocardial Infarction ‘Healing’?
por: Park, Kyung Woo
Publicado: (2019)

Ticagrelor Resistance in Cardiovascular Disease and Ischemic Stroke
por: He, Song, et al.
Publicado: (2023)

Ticagrelor versus clopidogrel in the management of acute myocardial infarction
por: Volney, Candice, et al.
Publicado: (2019)

Using Ticagrelor to Prevent Recurrent Type 1 and Type 2 Myocardial Infarctions: Boon or Bane?
por: Bittl, John A.
Publicado: (2018)

Effects of ticagrelor in a mouse model of ischemic stroke
por: Yamauchi, Keita, et al.
Publicado: (2017)

Ticagrelor-Induced Torsades de Pointes following Myocardial Infarction
por: Bu, Seong Hyeon, et al.
Publicado: (2022)

Long‐Term Risk of Myocardial Infarction Compared to Recurrent Stroke After Transient Ischemic Attack and Ischemic Stroke: Systematic Review and Meta‐Analysis
por: Boulanger, Marion, et al.
Publicado: (2018)

Nurse-led, telephone-based follow-up after acute coronary syndrome yields improved risk factors after 36 months: the randomized controlled NAILED-ACS trial
por: Henriksson, Robin, et al.
Publicado: (2021)

Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS–TIMI 54
por: Bonaca, Marc P., et al.
Publicado: (2018)

Effects of Ticagrelor and Clopidogrel on Coronary Microcirculation in Patients with Acute Myocardial Infarction
por: Scanavini-Filho, Marco Antonio, et al.
Publicado: (2022)

Implementation of a telephone-based secondary preventive intervention after acute coronary syndrome (ACS): participation rate, reasons for non-participation and 1-year survival
por: Huber, Daniel, et al.
Publicado: (2016)

Serious hemorrhages after ischemic stroke or TIA – Incidence, mortality, and predictors
por: Ögren, Joachim, et al.
Publicado: (2018)

Duration of Heightened Ischemic Stroke Risk After Acute Myocardial Infarction
por: Merkler, Alexander E., et al.
Publicado: (2018)

Paradoxical Myocardial Infarction After Thrombolytic Therapy for Acute Ischemic Stroke
por: Mohmand, Billal, et al.
Publicado: (2021)

Implementation of Ticagrelor Reduced Mortality in Routine Clinical Care: Evidence From a Natural Experiment Including 109 995 Patients With Myocardial Infarction in Sweden
por: Johannesen, Kasper, et al.
Publicado: (2023)

The dynamics of mortality in follow-up time after an acute myocardial infarction, lower extremity arterial disease and ischemic stroke
por: Vaartjes, Ilonca, et al.
Publicado: (2010)

Diurnal Variability of Platelet Aggregation in Patients with Myocardial Infarction Treated with Prasugrel and Ticagrelor
por: Adamski, Piotr, et al.
Publicado: (2022)

Low platelet reactivity in patients with myocardial infarction treated with aspirin plus ticagrelor
por: Costa, Thiago Guarato Rodrigues, et al.
Publicado: (2022)

Comparison between ticagrelor and clopidogrel in myocardial infarction patients with high bleeding risk
por: Tjerkaski, Jonathan, et al.
Publicado: (2023)

Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin
por: Amarenco, Pierre, et al.
Publicado: (2020)

Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack
por: Wang, Yongjun, et al.
Publicado: (2022)

Heart Rate Variability and Recurrent Stroke and Myocardial Infarction in Patients With Acute Mild to Moderate Stroke
por: von Rennenberg, Regina, et al.
Publicado: (2021)

Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel
por: Gasecka, Aleksandra, et al.
Publicado: (2020)

Ticagrelor Can Regulate the Ion Channel Characteristics of Superior Cervical Ganglion Neurons after Myocardial Infarction
por: Cheng, Lijun, et al.
Publicado: (2023)

Remote Ischemic Conditioning in Ischemic Stroke and Myocardial Infarction: Similarities and Differences
por: Saccaro, Luigi F., et al.
Publicado: (2021)

Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry
por: Basra, Sukhdeep S., et al.
Publicado: (2018)

Ticagrelor Can Be an Important Agent in the Treatment of Severe COVID-19 Patients with Myocardial Infarction
por: Akşit, Ercan, et al.
Publicado: (2020)

Safety and feasibility of low‐dose ticagrelor in patients with ST‐segment elevation myocardial infarction
por: Wang, Yanbo, et al.
Publicado: (2020)

Differential modulation of polyunsaturated fatty acids in patients with myocardial infarction treated with ticagrelor or clopidogrel
por: Samman, Karla N., et al.
Publicado: (2021)

Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack
por: Johnston, S. Claiborne, et al.
Publicado: (2021)

Ticagrelor Added to Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack in Prevention of Disabling Stroke: A Randomized Clinical Trial
por: Amarenco, Pierre, et al.
Publicado: (2020)

Nurse-led telephone-based follow-up of secondary prevention after acute coronary syndrome: One-year results from the randomized controlled NAILED-ACS trial
por: Huber, Daniel, et al.
Publicado: (2017)

Implementation of Telephone-Based Secondary Preventive Intervention after Stroke and Transient Ischemic Attack – Participation Rate, Reasons for Nonparticipation and One-Year Mortality
por: Irewall, Anna-Lotta, et al.
Publicado: (2014)

A randomized pilot study of the efficacy and safety of loading ticagrelor in acute ischemic stroke
por: Aref, Hany M., et al.
Publicado: (2022)

Implementation of a new guideline in cardiovascular secondary preventive care: subanalysis of a randomized controlled trial
por: Jakobsson, Stina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ujckg5ido317evvse6cum12efn